Human proximal tubular epithelial cells express somatostatin: Regulation by growth factors and cAMP

American Journal of Physiology - Renal Physiology

Volumn 274, Issue 6 43-6, 1998, Pages

  Turman, Martin A ^a,b   Apple, Courtney A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Epidermal growth factor; Hydrocortisone; Kidney; Paracrine; Somatotropin release inhibitory factor

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; HYDROCORTISONE; SOMATOSTATIN;

ARTICLE; CELL CULTURE; DATA ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONAL REGULATION; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SOMATOSTATIN RELEASE; SOUTHERN BLOTTING; THYROID CARCINOMA;

EID: 0031869647     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.274.6.f1095     Document Type: Article

References (41)

1. Albers, A. R., M. S. O'Dorisio, and A. J. Yates. Reverse-transcriptase polymerase chain reaction (RT-PCR) analysis of somatostatin receptor (SST) expression in neuroblastoma (Abstract). Soc. Neurosci. Abstr. 21: 2133, 1995.
2. Detrisac, C. J., M. A. Sens, A. J. Garvin, S. S. Spicer, and D. A. Sens. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int. 25: 383-390, 1984.
3. Dileepan, K. N., and S. R. Wagle. Somatostatin: a metabolic regulator. Life Sci. 37: 2335-2343, 1985.
4. Foegh, M. L., and P. W. Ramwell. Angiopeptin: experimental and clinical studies of inhibition of myointimal proliferation. Kidney Int. 48, Suppl. 52: S18-S22, 1995.
5. Gaginella, T. S., H. S. Mekhjian, and T. M. O'Dorisio. Vasoactive intestinal peptide: quantification by radioimmunoassay in isolated cells, mucosa, and muscle of the hamster intestine. Gastroenterology 74: 718-721, 1978.
6. Garcia-Escribano, C., M. L. 'Diez-Marques, M. Gonzalez-Rubio, M. Rodriguez-Puyol, and D. Rodriguez-Puyol. Somatostatin antagonizes angiotensin II effects on mesangial cell contraction and glomerular filtration. Kidney Int. 43: 324-333, 1993.
7. Garcia-Escribano, C., M. L. Diez-Marques, J. Medina-Alonso, M. Rodriguez-Puyol, and D. Rodriguez-Puyol. Somatostatin activates particulate guanylate cyclase in cultured rat mesangial cells. Kidney Int. 46: 1611-1615, 1994.
8. Gibson-D'Ambrosio, R. E., M. Samuel, C. C. Chang, J. E. Trosko, and S. M. D'Ambrosio. Characteristics of long-term human epithelial cell cultures derived from normal human fetal kidney. In Vitro Cell. Dev. Biol. 23: 279-287, 1987.
9. Goodman, R. H., R. P. Rehfuss, M. Verhave, R. Ventimiglia, and M. J. Low. Somatostatin gene regulation: an overview. Metabolism 39: 2-5, 1990.
10. Hatzoglou, A., E. Bakogeorgou, E. Papakonstanti, C. Stournaras, D. S. Emmanouel, and E. Castanas. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth. J. Cell. Biochem. 63: 410-421, 1996.
11. Hayry, P., A. Raisanen, J. Ustinov, A. Mennander, and T. Paavonen. Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. FASEB J. 7: 1055-1060, 1993.
12. Hofland, L. J., H. A. Visser-Wisselaar, and S. W. J. Lamberts. Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem. Pharmacol. 50: 287-297, 1995.
13. Ishikawa, S., T. Saito, and T. Kuzuya. Reversal of somatostatin inhibition of AVP-induced cAMP by pertussis toxin. Kidney Int. 33: 536-542, 1988.
14. Kronheim, S., M. Berelowitz, and B. L. Pimstone. The characterization of growth hormone release inhibiting hormone-like immunoreactivity in normal urine. Clin. Endocrinol. (Oxf.) 7: 343-347, 1977.
15. Liu, J. L., D. N. Papachristou, and Y. C. Patel. Glucocorticoids activate somatostatin gene transcription through cooperative interaction with the cyclic AMP signalling pathway. Biochem. J. 301: 863-869, 1994.
16. Liu, J. L., and Y. C. Patel. Glucocorticoids inhibit somatostatin gene expression through accelerated degradation of somatostatin messenger ribonucleic acid in human thyroid medullary carcinoma (TT) cells. Endocrinology 136: 2389-2396, 1995.
17. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
18. Minth, C. D., P. C. Andrews, and J. E. Dixon. Characterization, sequence, and expression of the cloned human neuropeptide Y gene. J. Biol. Chem. 261: 11974-11979, 1986.
19. Ng, S. Y., P. Gunning, R. Eddy, P. Ponte, J. Leavitt, T. Shows, and L. Kedes. Evolution of the functional human beta-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol. Cell. Biol. 5: 2720-2732, 1985.
20. O'Dorisio, M. S., F. Chen, T. M. O'Dorisio, D. Wray, and S. J. Qualman. Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ. 5: 1-8, 1994.
21. O'Dorisio, M. S., D. J. Fleshman, S. J. Qualman, and T. M. O'Dorisio. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Regul. Pept. 37: 213-226, 1992.
22. O'Dorisio, T. M., H. S. Mekhjian, E. C. Ellison, M. S. O'Dorisio, T. S. Gaginella, and E. A. Woltering. Role of peptide radioimmunoassay in understanding peptide-peptide interactions and clinical expression of gastroenteropancreatic endocrine tumors. Am. J. Med. 82: 60-67, 1987.
23. Pan, M. G., T. Florio, and P. J. Stork. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 256: 1215-1217, 1992.
24. Park, S. K., T. A. Olson, N. Ercal, M. Summers, and M. S. O'Dorisio. Characterization of vasoactive intestinal peptide receptors on human megakaryocytes and platelets. Blood 87: 4629-4635, 1996.
25. Patel, Y. C. General aspects of the biology and function of somatostatin. In: Somatostatin, edited by C. Weil, E. E. Muller, and M. O. Thorner. New York: Springer-Verlag, 1992, p. 1-16.
26. Patel, Y. C., M. T. Greenwood, R. Panetta, L. Demchyshyn, H. Niznik, and C. B. Srikant. The somatostatin receptor family. Life Sci. 57: 1249-1265, 1995.
27. Qualman, S. J., M. S. O'Dorisio, D. J. Fleshman, H. Shimada, and T. M. O'Dorisio. Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 70: 2005-2012, 1992.
28. Ray, C., S. Carney, T. Morgan, and A. Gillies. Somatostatin as a modulator of distal nephron water permeability. Clin. Sci. (Colch.) 84: 455-460, 1993.
29. Raynor, K., W. A. Murphy, D. H. Coy, J. E. Taylor, J. P. Moreau, K. Yasuda, G. I. Bell, and T. Reisine. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol. Pharmacol. 43: 838-844, 1993.
30. Reubi, J. C., U. Horisberger, U. E. Studer, B. Waser, and J. A. Laissue. Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta. J. Clin. Endocrinol. Metab. 77: 1323-1328, 1993.
31. Reubi, J. C., and L. Kvols. Somatostatin receptors in human renal cell carcinomas. Cancer Res. 52: 6074-6078, 1992.
32. + channel in insulin-secreting mammalian HIT and RIN cell lines. J. Physiol. (Lond.) 485: 73-86, 1995.
33. Rogers, D. G., G. J. Cote, E. S. Huang, and R. F. Gagel. 1,25-Dihydroxyvitamin D3 silences 3′,5′-cyclic adenosine monophosphate enhancement of somatostatin gene transcription in human thyroid C cells. Mol. Endocrinol. 3: 547-551, 1989.
34. Ruiz-Torres, P., F. J. Lucio, M. Gonzalez-Rubio, M. Rodriguez-Puyol, and D. Rodriguez-Puyol. A dual effect of somatostatin on the proliferation of cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 195: 1057-1062, 1993.
35. Shen, L. P., R. L. Pictet, and W. J. Rutter. Human somatostatin I: sequence of the cDNA. Proc. Natl. Acad. Sci. USA 79: 4575-4579, 1982.
36. Shtivelman, E., B. Lifshitz, R. P. Gale, B. A. Roe, and E. Canaani. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47: 277-284, 1986.
37. Storkel, S., and E. van den Berg. Morphological classification of renal cancer. World J. Urol. 13: 153-158, 1995.
38. Tsukada, T., S. J. Horovitch, M. R. Montminy, G. Mandel, and R. H. Goodman. Structure of the human vasoactive intestinal polypeptide gene. DNA (NY) 4: 293-300, 1985.
39. Turman, M. A., C. M. Bates, A. Mathews, and S. E. Haun. Effect of extracellular calcium on survival of human proximal tubular cells exposed to hypoxia. Ren. Fail. 17: 421-435, 1995.
40. Turman, M. A., M. S. O'Dorisio, T. M. O'Dorisio, C. A. Apple, and A. R. Albers. Somatostatin expression in human renal cortex and mesangial cells. Regul. Pept. 68: 15-21, 1997.
41. Zink, A., H. Scherubl, D. Kliemann, M. Hoflich, R. Ziegler, and F. Raue. Inhibitory effect of somatostatin on cAMP accumulation and calcitonin secretion in C-cells: involvement of pertussis toxin-sensitive G-proteins. Mol. Cell. Endocrinol. 86: 213-219, 1992.